Intranasal Administration of Melanin-Concentrating Hormone Reduces Stress-Induced Anxiety- and Depressive-Like Behaviors in Rodents

다국어 초록 (Multilingual Abstract)

Major depressive disorder is a complex neuropsychiatric disorder with few treatment options. Non-targeted antidepressants have low efficacy and can induce series of side effects. While a neuropeptide, melanin-concentrating hormone (MCH), is known to exhibit regulator of affective state, no study to date has assessed the anti-depressive effects of MCH in a stress-induced depression model. This study aimed to evaluate the pharmacological effects of intranasal administration of MCH on depression-related behavior in stressed rats and mice. Using a number of behavioral tests, we found that MCH treatment significantly decreased anxiety- and depressive-like behaviors induced by stress. Notably, the effects of MCH were equivalent to those of fluoxetine. MCH treatment also restored the activity of the mammalian target of rapamycin (mTOR) signaling pathway and normalized the levels of synaptic proteins, including postsynaptic density 95, glutamate receptor 1, and synapsin 1, which were all downregulated by stress. Interestingly, the protective effects of MCH were blocked by the mTOR inhibitor, rapamycin. These results suggest that MCH exhibits antidepressant properties by modulating the mTOR pathway. Altogether, this study provides an insight into the molecular mechanisms involved in the antidepressant-like effects of MCH, thereby paving the way for the future clinical application of MCH.

참고문헌 (Reference)

1 Laplante M, "mTOR signaling in growth control and disease" 149 : 274-293, 2012

2 Takei N, "mTOR signaling and its roles in normal and abnormal brain development" 7 : 28-, 2014

3 신말순, "Treadmill exercise improves depression-like symptoms by enhancing serotonergic function through upregulation of 5-HT1A expression in the olfactory bulbectomized rats" 한국운동재활학회 13 (13): 36-42, 2017

4 Cesca F, "The synapsins : key actors of synapse function and plasticity" 91 : 313-348, 2010

5 Macneil DJ, "The role of melanin-concentrating hormone and its receptors in energy homeostasis" 4 : 49-, 2013

6 Abelaira HM, "The role of mTOR in depression and antidepressant responses" 101 : 10-14, 2014

7 Monti JM, "The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement(REM)sleep" 14 : 319-327, 2010

8 Nahon JL, "The rat melanin-concentrating hormone messenger ribonucleic acid encodes multiple putative neuropeptides coexpressed in the dorsolateral hypothalamus" 125 : 2056-2065, 1989

9 Bittencourt JC, "The melanin-concentrating hormone system of the rat brain : an immuno-and hybridization histochemical characterization" 319 : 218-245, 1992

10 Hawes BE, "The melanin-concentrating hormone receptor couples to multiple G proteins to activate diverse intracellular signaling pathways" 141 : 4524-4532, 2000

11 World Health Organization, "The global burden of disease:2004 update" World Health Organization 2008

12 Smith DG, "The effects of stressful stimuli and hypothalamic-pituitary-adrenal axis activation are reversed by the melanin-concentrating hormone 1receptor antagonist SNAP 94847 in rodents" 197 : 284-291, 2009

13 Bencze J, "The Melanin-concentrating hormone system in human, rodent and avian brain" 13 : 264-269, 2018

14 Sakurada K, "Synapsin I is phosphorylated at Ser603 by p21-activated kinases(PAKs)in vitro and in PC12 cells stimulated with bradykinin" 277 : 45473-45479, 2002

15 Presse F, "Structure of the human melanin concentrating hormone mRNA" 4 : 632-637, 1990

16 Pittenger C, "Stress, depression, and neuroplasticity : a convergence of mechanisms" 33 : 88-109, 2008

17 Olivier B, "Serotonin : a never-ending story" 753 : 2-18, 2015

18 Urbanavicius J, "Prodepressive effect induced by microinjections of MCH into the dorsal raphe : time course, dose dependence, effects on anxiety-related behaviors, and reversion by nortriptyline" 25 : 316-324, 2014

19 Gehlert DR, "Preclinical evaluation of melanin-concentrating hormone receptor 1antagonism for the treatment of obesity and depression" 329 : 429-438, 2009

20 El-Husseini AE, "PSD-95 involvement in maturation of excitatory synapses" 290 : 1364-1368, 2000

21 Jang JH, "Novel analgesic effects of melanin-concentrating hormone on persistent neuropathic and inflammatory pain in mice" 8 : 707-, 2018

22 Ignácio ZM, "New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs" 82 : 1280-1290, 2016

23 Berton O, "New approaches to antidepressant drug discovery : beyond monoamines" 7 : 137-151, 2006

24 Kalia M, "Neurobiological basis of depression: an update" 54 (54): 24-27, 2005

25 Oh ST, "Nasal cavity administration of melanin-concentrating hormone improves memory impairment in memory-impaired and Alzheimer's disease mouse models" 56 : 8076-8086, 2019

26 Oh ST, "Nasal cavity administration of melanin-concentrating hormone improves memory impairment in memory-impaired and Alzheimer's disease mouse models" 56 : 8076-8086, 2019

27 Benedetto L, "Microinjection of melanin concentrating hormone into the lateral preoptic area promotes non-REM sleep in the rat" 39 : 11-15, 2013

28 Varas M, "Melanin-concentrating hormone, hippocampal nitric oxide levels and memory retention" 23 : 2213-2221, 2002

29 Ye H, "Melanin-concentrating hormone(MCH)and MCH-R1 in the Locus coeruleus may be involved in the regulation of depressive-like behavior" 21 : 1128-1137, 2018

30 Torterolo P, "Melanin-concentrating hormone(MCH) : role in REM sleep and depression" 9 : 475-, 2015

31 Pissios P, "Melanin-concentrating hormone receptor 1 activates extracellular signal-regulated kinase and synergizes with G(s)-coupled pathways" 144 : 3514-3523, 2003

32 Cotta-Grand N, "Melanin-concentrating hormone induces neurite outgrowth in human neuroblastoma SH-SY5Y cells through p53 and MAPKinase signaling pathways" 30 : 2014-2024, 2009

33 Krishnan V, "Linking molecules to mood : new insight into the biology of depression" 167 : 1305-1320, 2010

34 Basso AM, "Lack of efficacy of melaninconcentrating hormone-1 receptor antagonists in models of depression and anxiety" 540 : 115-120, 2006

35 Raymond CR, "LTP forms 1, 2 and 3: different mechanisms for the “long” in long-term potentiation" 30 : 167-175, 2007

36 Kameyama K, "Involvement of a postsynaptic protein kinase A substrate in the expression of homosynaptic long-term depression" 21 : 1163-1175, 1998

37 Serova LI, "Intranasal infusion of melanocortin receptor four(MC4R)antagonist to rats ameliorates development of depression and anxiety related symptoms induced by single prolonged stress" 250 : 139-147, 2013

38 Belzung C, "Innovative drugs to treat depression: did animal models fail to be predictive or did clinical trials fail to detect effects?" 39 : 1041-1051, 2014

39 Unmehopa UA, "Increased melanin concentrating hormone receptor type I in the human hypothalamic infundibular nucleus in cachexia" 90 : 2412-2419, 2005

40 Saito Y, "Expression of the melanin-concentrating hormone(MCH)receptor mRNA in the rat brain" 435 : 26-40, 2001

41 Frodl T, "Effect of hippocampal and amygdala volumes on clinical outcomes in major depression : a 3-year prospective magnetic resonance imaging study" 33 : 423-430, 2008

42 Reagan-Shaw S, "Dose translation from animal to human studies revisited" 22 : 659-661, 2008

43 Young EA, "Dissociation between pituitary and adrenal suppression to dexamethasone in depression" 50 : 395-403, 1993

44 American Psychiatric Association, "Diagnostic and statistical manual of mental disorders: DSM-5" American Psychiatric Association 2013

45 Lagos P, "Depressive-like profile induced by MCH microinjections into the dorsal raphe nucleus evaluated in the forced swim test" 218 : 259-266, 2011

46 Thorne RG, "Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration" 127 : 481-496, 2004

47 Banke TG, "Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase" 20 : 89-102, 2000

48 Koprdova R, "Chronic unpredictable mild stress paradigm in male Wistar rats: effect on anxiety- and depressive-like behavior" 37 (37): 103-110, 2016

49 Roche KW, "Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit" 16 : 1179-1188, 1996

50 Kawauchi H, "Characterization of melanin-concentrating hormone in chum salmon pituitaries" 305 : 321-323, 1983

51 Ahnaou A, "Blocking melanin-concentrating hormone MCH1 receptor affects rat sleep-wake architecture" 579 : 177-188, 2008

52 Chaki S, "Anxiolytic-and antidepressant-like profile of ATC0065 and ATC0175 : nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists" 313 : 831-839, 2005

53 Mashiko S, "Antiobesity effect of a melaninconcentrating hormone 1 receptor antagonist in diet-induced obese mice" 146 : 3080-3086, 2005

54 Borowsky B, "Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist" 8 : 825-830, 2002

55 Adams AC, "Ablation of the hypothalamic neuropeptide melanin concentrating hormone is associated with behavioral abnormalities that reflect impaired olfactory integration" 224 : 195-200, 2011

56 Roy M, "A study of the involvement of melanin-concentrating hormone receptor 1(MCHR1) in murine models of depression" 61 : 174-180, 2007

57 Qu D, "A role for melanin-concentrating hormone in the central regulation of feeding behaviour" 380 : 243-247, 1996